Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
Katherine L. Ullman
Advertisement
Katherine L. Ullman is president, KLU Consulting, LLC
Articles by Katherine L. Ullman
Advertisement
Latest Updated Articles
Understanding Concomitant Components in Pharmaceutical ExcipientsPublished: February 3rd 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Rare Disease Treatments: Navigating the Economics of Global Innovation
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
Women in STEM: Early Phase Drug Development
4
PharmTech Weekly Roundup - February 6, 2026
5